MGMT and salivary gland cancer: Six of the genes we evaluated, including cyclin-dependent kinase inhibitor 2A (p16), stratifin 14-3-3σ, RAS-associated domain family protein 1A (RASSF1A), retinoic acid receptor β (RAR-β), death-associated protein kinase (DAPK), and O6-methylguanine-DNA-methyltransferase (MGMT), were previously shown to be aberrantly methylated in salivary gland cancer [5], [7], [8], [11], [18], [19], [20].